Entecavir, FTC, L-FMAU, LdT and othersBUTI, Maria; ESTEBAN, Rafael.Journal of hepatology. Supplement. 2003, Vol 39, Num 1, pp S139-S142, issn 0169-5185Conference Paper

HEV identified in serum from humans with acute hepatitis and in sewage of animal origin in SpainPINA, Sonia; BUTI, Maria; COTRINA, Montserrat et al.Journal of hepatology. 2000, Vol 33, Num 5, pp 826-833, issn 0168-8278Article

Natural History and Management of Hepatitis C: Does Sex Play a Role?BADEN, Rachel; ROCKSTROH, Jürgen K; BUTI, Maria et al.The Journal of infectious diseases. 2014, Vol 209, issn 0022-1899, S81-S85, SUP3Article

Cost Effectiveness of First-Line Oral Antiviral Therapies for Chronic Hepatitis B: A Systematic ReviewBUTI, Maria; OYAGÜEZ, Itziar; LOZANO, Virginia et al.PharmacoEconomics (Auckland). 2013, Vol 31, Num 1, pp 63-75, issn 1170-7690, 13 p.Article

Financial impact of two different ways of evaluating early virological response to peginterferon-α-2b plus ribavirin therapy in treatment-naive patients with chronic hepatitis C virus genotype 1BUTI, Maria; CASADO, Miguel A; FOSBROOK, Leslie et al.PharmacoEconomics (Auckland). 2005, Vol 23, Num 10, pp 1043-1055, issn 1170-7690, 13 p.Article

Hepatitis B virus genome variability and disease progression : the impact of pre-core mutants and HBV genotypesBUTI, Maria; RODRIGUEZ-FRIAS, Francisco; JARDI, Rosendo et al.Journal of clinical virology. 2005, Vol 34, issn 1386-6532, S79-S82, SUP1Conference Paper

A comparative study of ultra-deep pyrosequencing and cloning to quantitatively analyze the viral quasispecies using hepatitis B virus infection as a modelRAMIREZ, Clara; GREGORI, Josep; BUTI, Maria et al.Antiviral research. 2013, Vol 98, Num 2, pp 273-283, issn 0166-3542, 11 p.Article

Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: Findings from the Antiretroviral Pregnancy RegistryBROWN, Robert S; VERNA, Elizabeth C; PEREIRA, Marcus R et al.Journal of hepatology. 2012, Vol 57, Num 5, pp 953-959, issn 0168-8278, 7 p.Article

Entecavir Treatment for Chronic Hepatitis B: Adaptation Is Not Needed for the Majority of Naïve Patients with a Partial Virological ResponseZOUTENDIJK, Roeland; REIJNDERS, Jurrien G. P; VAN BÖMMEL, Florian et al.Hepatology (Baltimore, Md.). 2011, Vol 54, Num 2, pp 443-451, issn 0270-9139, 9 p.Article

Early HBeAg Loss During Peginterferon α-2b Therapy Predicts HBsAg Loss: Results of a Long-Term Follow-Up Study in Chronic Hepatitis B PatientsBUSTER, Erik H. C. J; FLINK, Hajo J; HANSEN, Bettina E et al.The American journal of gastroenterology. 2009, Vol 104, Num 10, pp 2449-2457, issn 0002-9270, 9 p.Article

Faldaprevir and Deleobuvir for HCV Genotype 1 InfectionZEUZEM, Stefan; SORIANO, Vincent; GANE, Ed J et al.The New England journal of medicine. 2013, Vol 369, Num 7, pp 630-639, issn 0028-4793, 10 p.Article

Modeling the cost-effectiveness of different oral antiviral therapies in patients with chronic hepatitis BBUTI, Maria; BROSA, Max; CASADO, Miguel A et al.Journal of hepatology. 2009, Vol 51, Num 4, pp 640-646, issn 0168-8278, 7 p.Article

Analysis of hepatitis B genotype changes in chronic hepatitis B infection : Influence of antiviral therapyJARDI, Rosendo; RODRIGUEZ-FRIAS, Francisco; SCHAPER, Melanie et al.Journal of hepatology. 2008, Vol 49, Num 5, pp 695-701, issn 0168-8278, 7 p.Article

Hepatitis A and B in children and adolescents : what can we learn from puglia (Italy) and Catalonia (Spain)?LOPALCO, Pier Luigi; SALLERAS, Lluis; BARBUTI, Salvatore et al.Vaccine. 2000, Vol 19, Num 4-5, pp 470-474, issn 0264-410XArticle

Effectiveness and Cost-effectiveness of Immediate Versus Delayed Treatment of Hepatitis C Virus―Infected Patients in a Country With Limited Resources: The Case of EgyptOBACH, Dorothée; DEUFFIC-BURBAN, Sylvie; BUTI, Maria et al.Clinical infectious diseases. 2014, Vol 58, Num 8, pp 1064-1071, issn 1058-4838, 8 p.Article

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 InfectionAFDHAL, Nezam; ZEUZEM, Stefan; FOSTER, Graham R et al.The New England journal of medicine. 2014, Vol 370, Num 20, pp 1889-1898, issn 0028-4793, 10 p.Article

Efficacy and safety of entecavir in clinical practice in treatment-naive Caucasian chronic hepatitis B patientsBUTI, Maria; MORILLAS, Rosa Maria; RODRIGUEZ, Manuel et al.European journal of gastroenterology & hepatology. 2012, Vol 24, Num 5, pp 535-542, issn 0954-691X, 8 p.Article

Tenofovir Disoproxil Fumarate versus Adefovir Dipivoxil for Chronic Hepatitis BMARCELLIN, Patrick; HEATHCOTE, E. Jenny; MANNS, Michael et al.The New England journal of medicine. 2008, Vol 359, Num 23, pp 2442-2455, issn 0028-4793, 14 p.Article

Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremiaZEUZEM, Stefan; BUTI, Maria; ALBRECHT, Janice et al.Journal of hepatology. 2006, Vol 44, Num 1, pp 97-103, issn 0168-8278, 7 p.Article

Usefulness of dried blood samples for quantification and molecular characterization of HBV-DNAJARDI, Rosendo; RODRIGUEZ-FRIAS, Francisco; BUTI, Maria et al.Hepatology (Baltimore, Md.). 2004, Vol 40, Num 1, pp 133-139, issn 0270-9139, 7 p.Article

Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/ TDF, and Entecavir in Patients with Decompensated Chronic Hepatitis B Liver DiseaseLIAW, Yun-Fan; SHEEN, I-Shyan; BUTI, Maria et al.Hepatology (Baltimore, Md.). 2011, Vol 53, Num 1, pp 62-72, issn 0270-9139, 11 p.Article

Antiviral effect of entecavir in chronic hepatitis B: Influence of prior exposure to nucleos(t)ide analoguesREIJNDERS, Jurriën G. P; DETERDING, Katja; PETERSEN, Jörg et al.Journal of hepatology. 2010, Vol 52, Num 4, pp 493-500, issn 0168-8278, 8 p.Article

Randomized Trial of Peginterferon alfa-2b and Ribavirin for 48 or 72 Weeks in Patients with Hepatitis C Virus Genotype 1 and Slow Virologic ResponseBUTI, Maria; LURIE, Yoav; PEDICONE, Lisa D et al.Hepatology (Baltimore, Md.). 2010, Vol 52, Num 4, pp 1201-1207, issn 0270-9139, 7 p.Article

A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantationBUTI, Maria; MAS, Antoni; PRIETO, Martin et al.Journal of hepatology. 2003, Vol 38, Num 6, pp 811-817, issn 0168-8278, 7 p.Article

Page / 3